Rourke Baby Record Guide 5
Any areas/items that have additional information available are highlighted in blue. To explore the additional information, simply click on a highlighted area and an information panel will open. To close the information panel click on the X icon in the upper right-hand corner of the panel.
The interactive elements on this page require Javascript to run properly.
Diphtheria, Tetanus, acellular Pertussis and inactivated Polio virus vaccine (DTaP-IPV): DTaP-IPV vaccine is the preferred vaccine for all doses in the vaccination series, including completion of the series in children < 7 years who have received ≥ 1 dose of DPT (whole cell) vaccine (e.g., recent immigrants).
Haemophilus influenzae type b conjugate vaccine (Hib): Hib schedule shown is for the Haemophilus b capsular polysaccharide – PRP conjugated to tetanus toxoid (Act-HIBTM) or the Haemophilus b oligosaccharide conjugate - HbOC (HibTITERTM) vaccines. This vaccine may be combined with DTaP in a single injection.
Pneumococcal conjugate vaccine - 7-valent (Pneu-Conj): Recommended schedule, number of doses and subsequent use of 23 valent polysaccharide pneumococcal vaccine depend on the age of the child, if at high risk for pneumococcal disease, and when vaccination is begun.
Meningococcal conjugate vaccine (Men-C): Monovalent vaccine to Type C (Men-C-C) is indicated for all ages, and quadravalent to Types A/C/W/Y (Men-C-ACWY) for age 2 yrs and over. Recommended vaccine, schedule and number of doses of meningococcal vaccine depend on the age of the child and vary between provinces/territories. Possible schedules include:
- Men-C-C: 2 - 3 doses under 12 mos of age AND booster dose between 12 - 24 mos age.
- * OR *
- Men-C-C: 1 dose at 12 mos of age.
Men-C-C or Men-C-ACWY booster dose should also be given at 12 yrs of age or during adolescence.
Hepatitis B vaccine (Hep B): Hepatitis B vaccine can be routinely given to infants or preadolescents, depending on the provincial/territorial policy. For infants born to chronic carrier mothers, the first dose should be given at birth (with Hepatitis B immune globulin), otherwise the first dose can be given at 2 months of age to fit more conveniently with other routine infant immunization visits. The second dose should be administered at least 1 month after the first dose, and the third at least 2 months after the second dose, but again may fit more conveniently into the 4- and 6-month immunization visits. A two-dose schedule for adolescents is an option.
Measles, Mumps and Rubella vaccine (MMR): A second dose of MMR is recommended, at least 1 month after the first dose for the purpose of better measles protection. For convenience, options include giving it with the next scheduled vaccination at 18 months of age or at school entry (4-6 years) (depending on the provincial/territorial policy), or at any intervening age that is practical. The need for a second dose of mumps and rubella vaccine is not established but may benefit (given for convenience as MMR). The second dose of MMR should be given at the same visit as DTaP-IPV (± Hib) to ensure high uptake rates. MMR and varicella vaccines should be administered concurrently (at different sites if the combined MMR/varicella vaccine is not available) or separated by at least 4 weeks.
Varicella vaccine: Children aged 12 months to 12 years who have not had varicella should receive one dose of varicella vaccine. Unvaccinated individuals ≥ 13 years who have not had varicella should receive two doses at least 28 days apart. Varicella and MMR vaccines should be administered concurrently (at different sites if the combined MMR/varicella vaccine is not available) or separated by at least 4 weeks.
Diphtheria, Tetanus, acellular Pertussis vaccine - adult/adolescent formulation (dTap) a combined adsorbed “adult type” preparation for use in people ≥ 7 years of age, contains less diphtheria toxoid and pertussis antigens than preparations given to younger children and is less likely to cause reactions in older people. This vaccine should be used in individuals > 7 years receiving their primary series of vaccines.
Influenza vaccine (Flu): Recommended for all children between 6 and 23 months of age, and for older high-risk children. Previously unvaccinated children up to 9 years of age require 2 doses with an interval of at least 4 weeks. The second dose is not required if the child has received one or more doses of influenza vaccine during the previous immunization season.
HPV: Need content